Biogen Stock: How Biogen Makes Money In 2022 And How They Defied Gravity
Copyright 2022 Forbes Media LLC
business
2022-10-15 13:45:00

|Getty Images
Key Takeaways Biogen has seen its stock price skyrocket after groundbreaking news about its new Alzheimer's treatment that could improve the lives of millions of Americans, and billions worldwide. Biogen desperately needed some good news after its previous Alzheimer's treatment, Aduhelm, was a commercial flop. Biogen discovers, develops, and delivers innovative therapies worldwide to people who suffer from serious neurological diseases. 
 You may have heard the overwhelmingly positive news for Biogen latelyâ€”this stock has been a rare winner during a time of extreme volatility in the stock market due to consistent rate hikes.
